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The guinea pig is susceptible to most strains of the virus of herpes, 
but there are certain ones, such as the Levaditi souche C, which, on 
intracerebral inoculation in this animal,  1 are inactive.  Flexner  2 has 
shown that such differences are explainable on the basis of variations 
in  virulence,  weak  strains  being  implanted on  the  cerebrum with 
difficulty and strong strains with ease.  An interesting analogue to 
this condition may be found in such a widely different infectious agent 
as  the filtrable virus of foot-and-mouth disease.  Among  types  of 
this virus some may be found which are easily transferred to guinea 
pigs (Type A, for example),~ while others are not. 
The resistance of the guinea pig to some strains of herpes virus has 
been  recently  emphasized by  Dmitrieff  4 and  Rose  and  Walthard.  5 
They consider that the behavior of the animal in this regard offers a 
possible solution to the problem of the etiology of epidemic encephali- 
tis in man.  Their idea is that the inability to transfer this disease 
from man to rabbits may be explained by a natural resistance such as 
that  manifested by  guinea pigs  to  herpes  virus.  Flexner,  ~ on  the 
other hand, has brought out the point that the guinea pig merely acts 
to  discriminate strong  from weak  strains  of herpes  virus.  Conse- 
quently the recognition of this factor does not aid in the solution of the 
etiology of epidemic encephalitis. 
t Flexner, S., and Amoss, H. L., J. Exp. Med., 1925, xli, 233. 
Flexner,  S., Y. Exp. Med.,  1928, xlvii, 23. " 
30litsky, P. K., Tram, J'., and Schoening, H. W., Report of the Foot-and- 
Mouth Disease  Commission of the United States Department of Agriculture, 
1928, Teck. Bull. 76. 
4  Dmitrieff, S., Z. Hyg. u. Infektionskrankk.,  1926, cvi, 547. 
Rose, G., and Walthard, B., Z. Hyg. u. Infektionskrankk.,  1925-26, cv, 645. 
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In this paper we intend to present the results of attempts to implant 
a weak strain of herpes virus on the cerebrum of the guinea pig by the 
use of special methods.  In some of the tests dermo- and neurovaccine 
viruses were used.  The experiments included a  study of the nature 
of the barrier  to implantation of weak strains,  as well as one of im- 
munity reactions to both weak and strong strains. 
In carrying out the following tests, we employed as a sample of a weak strain 
of herpes virus the Levaditi C strain which, in agreement with previous findings,  2 
has failed  to infect a  large  number of guinea  pigs  after ordinary intracerebral 
inoculation.  In some tests this virus was used by itself, and in others in combina- 
tion with the viruses of vesicular stomatitis of horses,  a or of vaccinia, both dermo- 
vaccine and neurovaccine. 6  Experiments  of the latter sorts involved necessarily 
a study of the individual  effects of the vesicular stomatitis and vaccine viruses in 
the guinea pig, so that  the action of these  when combined  with the Levaditi 
strain  could  be properly understood.  For certain purposes,  a  strong strain of 
herpes virus was needed.  We then used the H.F.  t and the J'.B. 7 strains. 
The methods employed in preparing suspensions of brain for inoculation,  the 
manner of injection,  and the observations  of treated animals  followed the pro- 
cedures of Flexner and Amoss, 7 unless otherwise stated. 
Survival of Herpes Virus (Levaditi Strain) in the Brain of the Guinea Pig. 
The first series of experiments  * related  to a  study of the period of 
survival  of  the  Levaditi  strain  of herpes  virus  in  the  brain  of  the 
guinea pig. 
For this purpose,  a number of guinea pigs, as shown in Table I, were injected 
intracerebrally in one hemisphere,  with controlled,  active Levaditi virus, as con- 
tained  in  the  cerebral  tissue  of  rabbits  dying  from  virus  encephalitis.  The 
amount of active rabbit brain used for inoculation  of the guinea pigs was, as a 
rule, 0.2 cc. of a 10 per cent saline suspension.  After various periods of time, the 
animals were killed and a fragment of forebrain, usually about 0.5 gm. in weight, 
was removed in a sterile manner from a region showing the track of the needle. 
A 10 per cent saline suspension of this fragment was made and 0.4 cc. inoculated 
intracerebrally into each of two rabbits.  The animals  were then closely studied 
for any indication  of virus encephalitis.  The brains  of the rabbits  which  suc- 
6 For two samples of neurovaccine  placed at our disposal, we are indebted for 
one to Dr. Rivers, of The Rockefeller Institute, who had originally  received the 
strain from Professor Levaditi, and for the other to Professor Levaditi himself. 
7 Flexner, S., and Amoss, H. L., J. Exp. Med., 1925, xU, 215. 
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cumbed, or were etherlzed when moribund, were sectioned and stained, and ex- 
amined for the characteristic lesions of infiltrative meningoencephalitis, and for 
TABLE  I. 
Period  of Survival  of Levaditi  Virus in Guinea  Pigs' Brains; as Demonstrated  by 
Inoculations  of the Brain Tissue into Rabbits. 
Series 
A 
B 
C 
Days after 
intracerebral 
injec.tion of the 
guinea plgs 
2 
3 
4 
5 
6* 
Effects on the rabbits 
No reaction 
I of 2 rabbits showed characteristic  virus  encephalitis; 
death on 4th day 
1 of  2  rabbits showed characteristic  virus encephalitis; 
death on 5th day 
No reaction 
2 rabbits  showed characteristic  virus  encephalitis;  death 
on  7th  and  9th  days  respectively 
No reaction 
2 rabbits  showed characteristic  virus  encephalitis;  death 
on  9th  and 11th  days  respectively 
No reaction 
2 rabbits showed characteristic  virus encephalitis;  death 
on 5th day in one instance and moribund on 5th day in 
the other 
No reaction 
1  of  2  rabbits showed characteristic  virus encephalitis; 
death on 9th day 
* In an additional experiment two guinea pigs from which the cerebral frag- 
ments were removed 9 days after inoculation  of virus failed to reveal the presence 
of virus by the rabbit test. 
the  typical intranudear inclusion bodies.  Cultures of  the  brains in chopped 
meat medium and in dextrose broth were also made to rule out the action of 
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It will be noted in the experiments of Series A  that the brains of 
guinea pigs inoculated with the Levaditi virus were not active on the 
2nd and 3rd days after cerebral injection, but were active on the 4th 
and 5th days.  Thereafter, to the 9th day after injection, the virus 
could not be detected by means of the rabbit test.  Also in Series B, 
virus was obtained from the guinea-pigs' brains on the 1st and 5th 
days after injection, but not on the 2nd, 3rd, 4th, and 6th days.  In 
Series C, virus could be demonstrated by the rabbit test on the 1st 
and 6th days after inoculation, but not on the 2nd to 5th days, and in 
an additional experiment, not on the 9th day. 
One may suppose that the Levaditi strain of herpes virus, after its 
introduction into the brain of the guin za pig, remained there for 24 
hours after inoculation in a  concentration suffident to show activity 
when the inoculated area was transferred to the cerebrum of the sus- 
ceptible rabbit.  In other words, a passive transfer of the virus might 
have occurred, explaining the positive results at  this time.  There- 
after, up to about the 4th day the virus was not detected.  During 
this  period, we believe the virus to have  scattered throughout the 
cerebrum, and since it again became demonstrable by the rabbit test 
on the 4th to 6th day after injection, it probably increased in amount 
during this time.  Thereafter it was not again demonstrable, a  fact 
which would imply its final neutralization or elimination.  It is im- 
portant to note that during all  this time the guinea pigs appeared 
healthy, and those brains removed for injection into rabbits were free 
from distinctive histopathological changes. 
The brain of a  guinea pig which had been found to contain virus 
failed to produce virus encephalitis after 53 days glycerolation, unlike 
glycerolated rabbit brains in which the virus survives for an indefinite 
period.  From this experiment one might perhaps infer that in the 
guinea pig brain the concentration of virus was less than in the rabbit 
brain. 
Neutralization  Tests with Serum. 
The following tests were made to determine whether any neutraliz- 
hag factor for herpes virus exists in normal guinea pig serum. 
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Preparation of  Virus.--The  source of  the  Levaditi  herpes virus  was  fresh 
cerebral tissue of a rabbit dying from 3 to 7 days after intracranial inoculation o~: 
the virus.  A 10 per cent saline suspension was made which was filtered without: 
pressure through one layer of filter paper, for the purpose of removing the larger 
particles.  In one test the H.F. strain of virus was similarly prepared and used 
as a control. 
Preparation of  Serum.--Two or three full grown guinea pigs were bled by cardiac 
puncture.  The blood was pooled and kept at 37°C. for about an hour until the 
serum separated from the clot, when it was centrifugalized.  In some tests, part 
of the serum was heated at 56°C. for ½  hour to destroy complement; the remainder 
was used in a fresh state. 
Plan of Test.--As a  rule, five tubes were preparext with 0.1 or 0.2 cc. of the 
paper-filtrate virus.  To the first tube, 2 cc. of saline solution was added (control), 
to the second and third, 2 cc. and 1 cc. of inactivated serum were added, and to 
the fourth and fifth, 2 cc. and 1 cc. of fresh serum.  The mixtures were repeatedly 
shaken and placed at 37°C. for 1 hour, and then overnight in the ice box at 5°C. 
Rabbits were then inoculated intracerebrally with 0.35 to 0.4 cc. of each of the 
mixtures to determine the survival of the virus. 
In addition to these experiments, another one was made in which suspensions 
of normal guinea pig brain were added to the virus instead of the serum. 
To summarize the results,  suspensions of cerebral tissue or inacti- 
vated serum from normal guinea pigs failed to neutralize the  virus. 
With fresh, normal guinea pig serum,  however, complete neutraliza- 
tion was  effected in one experiment, the incubation period was  pro- 
tracted to 11  and  13 days respectively (as compared with 6  and 7 in 
the  controls)  in  two  others,  and  no  neutralization  occurred  in  the 
last.  In  the  case of the  H.  F.  strain  of herpes virus,  to which  the 
guinea pig,  as a  rule, responds with encephalitis, neither inactivated 
nor fresh serum neutralized the virus.  It may be concluded that the 
results,  although  not  entirely consistent,  suggest  that  fresh,  normal 
guinea pig serum has a  neutralizing action on the Levaditi virus. 
Inoculation  of Levaditi  Virus  Alone. 
The  next  series  of  experiments  involved  attempts  to  produce 
encephalitis in guinea pigs with the Levaditi virus, by various soecial 
means.  To obtain active virus,  we employed fresh, non-glycerolated 
brains removed from rabbits either in the terminal stages of Levaditi- 
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The first method involved the inoculation  into the brain of a large amount of 
virus  (0.05 to 0.1  cc. of a  10 per cent rabbit brain suspension)  into three ap- 
parently healthy, 1 week old guinea pigs.  Young animals were used to ascertain 
whether they might be less resistant. 
The second attempt included  the subdural injection  of massive  doses of the 
virus, that is, 0.2 cc. of a 10 per cent rabbit brain suspension into each side of the 
forebrain of normal 250 gm. guinea pigs.  It was believed that this saturation of 
the brain to the limit imposed by the operative technique  might yield different 
results from the usual injection of 0.15 cc. into one hemisphere. 
In  the  third  instance,  medium-sized  guinea pigs  were  inoculated intraperi- 
toneally with massive  doses of Levaditi virus  (5  and 10 cc. of the usual fresh 
brain suspension) and at the same time intracerebrally with the ordinary amount 
--0.15 cc.  In this series the attempt was made to saturate the body with virus 
and reduce the general resistance. 
The fourth test consisted  of the intracerebral passage  of the virus at 5 day 
intervals through three successive series of guinea pigs.  We aimed at the en- 
hancement of the virulence  of Levaditi virus by repeated  transfer of cerebral 
tissue  at a period corresponding  to the maximum concentration of the virus, as 
shown in the first set of tests. 
In a fifth experiment,  we made use of the method of Teague and Goodpasture  9 
who reported increase in virulence  of herpes virus after its inoculation  into the 
tarred  skin  of guinea pigs.  Seven young, white-furred  guinea  pigs  were  sub- 
jected to treatment with Holland tar.  Acting upon the finding of Teague and 
Goodpasture, that the sensory nerves and posterior root ganglia corresponding to 
the area of skin treated are affected, we applied  the tar as close to the head as 
possible.  The liquid  was painted on the back of the neck and upper posterior 
chest four times at 3 to 4 day intervals.  At the end of the period,  the skin was 
hairless  and hypertrophic.  10 per cent saline suspensions of fresh rabbit brain 
containing  active Levaditi virus were then rubbed into the scarified areas,  and 
injected  intracutaneously  into  five  of  the  pigs;  the  remaining  two  served  as 
controls.  The virus treatment was repeated after 48 hours and  again  after 5 
days. 
In the sixth  test the Levaditi virus,  as contained  in  rabbit brains,  was inocu- 
lated into the scarified cornea~ of guinea  pigs.  Suspensions of  scrapings  of the 
cornea  of these  animals  were  inoculated  into normal guinea pigs,  in this way 
propagating the virus through five successive corneal passages, in twenty animals. 
None of these six methods served to establish  specific encephalitis 
in  guinea  pigs.  Neither  were  any local  specific lesions  manifest  in 
any  instance,  except  in  the one  in  which  the  virus  was  inoculated 
into the cornea.  In the series of corneal inoculations, all guinea pigs 
9 Teague,  O.,  and Goodpasture,  E. W., J. Med. Research, 1923, xliv,  185. PETER  K.  OLITSKY  AND  PERRIN  H.  LONG  385 
of the first to  the fifth passages  showed a  definite but mild  kerato- 
conjunctivitis, from which they recovered without showing cerebral 
symptoms. 
In yiew of the finding, however,  recorded in the first experiment, 
namely, that the Levaditi virus increases in quantity in the brains of 
guinea pigs,  another mode of definite implantation of the virus was 
still searched for, and one was found. 
The procedure  consisted merely in  a  combination of  corneal  and 
subdural inoculation of the Levaditi virus into the same guinea pig at 
different times. 
Two guinea pigs were injected intracerebraUy  with 0.2 cc. of a  20 per cent 
saline suspension of fresh rabbit brain containing Levaditi virus.  At the same 
time, the scarified left cornea was inoculated with the same suspension of virus. 
The next day the animals  revealed  definite  keratoconjunctivitis.  On  the 3rd 
day after the first treatment, the animals were inoculated in the scarified right 
cornea with the corneal scrapings derived from a guinea pig with keratoconjunc- 
tivitis resulting  from a corneal virus inoculation.  On the 4th day both eyes of 
each animal exhibited  keratoconjunctivitis.  On the 6th and 7th days respec- 
tively, both guinea pigs became hypersensitive  and showed circling movements, 
tremors, involuntary muscular contractions, urine retention, gnashing, and marked 
salivation.  When moribund, they were killed and the brains removed for culture, 
histopathology, glycerolation,  and for further guinea pig passages.  In gross the 
brains were quite normal, except  for a  slight injection; the other organs  were 
unaffected.  Cultures of cerebral tissues gave no growth.  Microscopic examina- 
tion of the brains  disclosed  the  severe,  infiltrative meningoencephalitis  char- 
acteristic of herpes-virus  encephalitis  in rabbits and guinea pigs.  There were 
also present large  numbers of intranuclear inclusion  bodies typical of herpetic 
infection. 
This experiment  was repeated three times with the same outcome in each. 
Thus,  finally, characteristic herpes-virus  encephalitis was induced 
in the guinea pig with the Levaditi strain.  Moreover, the effects were 
obtained through seven successive gxfinea pig passages:  1°  the first to 
the third by the special combination of subdural and corneal inocula- 
tions;  the  remaining passages  by intracerebral  injections only.  On 
transfer  of  the  suspensions  of  cerebral  tissue  to  rabbits'  corne~e  or 
brains,  the latter developed  typical herpes-virus  effects followed by 
10 After four to five successive passages in the guinea pig, with subdural inocu- 
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death  from  encephalitis.  Furthermore,  after  the  virus  acquired  its 
encephalitogenic  property,  the  usual  dose  employed  with  strong 
strains  (the H.F.,  for example)  sufficed to  induce  the  characteristic 
encephalitis in guinea pigs.  Moreover, the encephalitogenic Levaditi 
virus  behaved like  strong  strains  in guinea  pigs  in  that  the kerato- 
conjunctivitis tended often, to complete recovery.  As is also the case 
with  strong  strains  injected  intracerebrally  in guinea  pigs,  recovery 
would occasionally occur in an  animal  of a  series which showed the 
characteristic signs of encephalitis. 
Having succeeded in adapting  the Levaditi C virus to guinea pigs 
by the double method of inoculation described, the concomitant effects 
of the viruses of vesicular stomatitis and of vaccinia were next tested. 
Concomitant  Effects  of Levaditl  Virus  and  Other  Viruses. 
Recent  reports  have  shown  the  growth  and  survival  of  vaccine 
virus in tumors of mice and  rats  (Levaditi  and  Nicolaun),  of Virus 
III,  and  vaccine virus  in  a  transplantable  rabbit  neoplasm  (Rivers 
and Pearcel~), and the enhancement of the effects of syphilis in rabbits 
with vaccinia (Pearce13).  Levaditi and  Nicolau  1. have reported  also 
on the concomitant  action of herpes and  vaccine viruses in rabbits, 
through  which vaccine virus was rendered more active and made to 
induce  characteristic  encephalitis. 
For experimental purposes the virus of vesicular stomatitis  of horses, already 
described  3, t5 and vaccine virus were used.  The latter was generously supplied 
by the New York City Health Department  Research Laboratories. 
Vesicular Stomatitis Virus.--This  material  consisted of  a  fixed guinea  pig 
passage virus, propagated  through several hundred animals.  It was capable of 
inducing characteristic  vesicles in the pads and corne,e of the animals 24 to 48 
hours after inoculation, but was free from neurotropic action. 
Vaccine Virus.--The virus consisted of calf lymph that was active in the skin, 
testicle,  and cornea of guinea pigs, producing typical vaccinal lesions within  2 
to 4 days after inoculation.  This sample of virus was not neurotropic, failing to 
induce encephalitis after intracerebral inoculation of guinea pigs. 
n Levaditi, C., and Nicolau, S., Ann. Inst. Pasteur, 1923, xxxvii, 443. 
t~ Rivers, T. M., and Pearce, L., J. Exp. Med., 1925, xlii, 523. 
t~ Pearce, L., ]. Exp. Med., 1928, xlvii, 611. 
t4 Levaditi,  C., and Nicolau, S., Compt. rend. Soc. biol., 1925, xciii, 3. 
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Tests.--Different  combinations  of viruses  were made,  as follows: Levaditi C 
virus was injected intracerebrally  in guinea pigs of all the series.  In two of the 
series, vesicular stomatitis and vaccine viruses were also inoculated intracerebrally 
at the same time.  In a third series, vesicular stomatitis virus was injected in the 
pads  at  the  time  the Levaditi  virus  was introduced  into  the  brain;  and in  a 
fourth,  vaccine  virus  was  injected  intracutaneously.  In  each  instance  the 
viruses by themselves were found to be active; the Levaditi virus in control rab- 
bits,  and the vesicular  stomatitis and vaccine viruses  in control guinea pigs. 
The simultaneous injection of Levaditi virus in the brain and vesic- 
ular  stomatitis or dermatotropic vaccine virus also in the brain, or in 
the skin,  failed,  on the other hand,  to produce any cerebral effect. 
In the next experiments two specimens of neurovaccine were used in 
additional tests on the combined action of the viruses.  The neurovac- 
cine was much more active than the dermatotropic sample in the skin, 
cornea,  and  testes  of guinea pigs. 
Characteristics of Neurovaccine Virus.--The  samples  of  neurovaccine  virus 
were alike in their action in animals. 
In rabbits injected intracerebrally,  the virus acted in a manner similar  to the 
herpes  virus.  The symptoms shown by  the inoculated  animals  were identical, 
except  that in the case of neurovaccine virus the experimental  disease was more 
severe; the first signs were manifest  within 48 hours after inoculation,  and death 
ensued, as a rule, within 72 to 96 hours.  The histopathology of the brains  con- 
sisted  of infiltrative  meningoencephalitis,  but the characteristic  intranuclear in- 
clusion bodies of herpes encephalitis  were absent. 
The neurovaccine  virus differs from herpes virus in the failure  to show cross- 
immunity reactions.  Rabbits  recovered  from keratoconjuncfivitis  induced  by 
the H.F. II strain of herpes virus  x6 were not resistant to later intracerebral  injec- 
tions  of  neurovaccine  virus.  Furthermore,  the  neurovaccine  virus  produced 
characteristic  vesicular kerafitis in rabbits and Guarnieri bodies were found in the 
lesions.  Finally,  the virus was active in the skin and testes of rabbits, in which 
typical vaccinal  eruption or the orchitis was produced. 
The effects  of neurovaccine  in guinea pigs  differ from those  in rabbits  to a 
noteworthy degree.  After intratesticular injection  an orchifis developed on the 
2nd  day  which  tended  to  heal  rapidly.  No  cerebral  involvement  followed. 
After intradermic inoculation,  characteristic  vesicles  appeared  on the 2nd day 
with no encephalitic  complication.  Corneal injection  was followed by a kerato- 
conjunctivitis  on  the  2nd  day without  cerebral  involvement.  Finally,  intra- 
cerebral inoculation of neurovaccine virus was without any specific action.  Thus 
the neurovaccine  produced milder  lesions in the guinea pig than in the rabbit, 
and in the guinea pig it was inactive  in the brain. 
16 Flexner,  S., J. Exp. Med.,  1928, xlvii,  9. 388  HERPES  VIRUS  AND  VACCINE  VIRUS 
It is  evident that  the neurovaccine virus,  although distinct  from 
herpes virus, acts in rabbits and guinea pigs in a manner  comparable 
to the Levadifi C virus itself.  For, while it produces  an encephalitis 
in rabbits, it does not do so in guinea pigs.  It does, however,  induce 
local lesions in guinea pigs after intradermal, corneal,  and  tesficular 
injection, which are manifest, as a  rule, 2 days after inoculation. 
In combining neurovaccine virus with the Levaditi C strain of herpes 
virus in the effort to evoke an encephalitogenic effect of the latter in 
guinea pigs, it was believed that success might follow the injection of 
the  two  viruses  at  different times,  so  that  both  would  eventually 
operate  at  the  same  period  with maximum intensity.  We  had  al- 
ready determined this period for neurovaccine virus, namely, 2 days. 
Earlier in this paper, we have shown that the time of maximum activity 
of the Levaditi strain of herpes  virus in the brains  of guinea pigs is 
from 4  to 6 days after its intracerebral injection. 
Combined E~ec~s of Levaditi Herpes Virus and  Neurovacclne Virus. 
The following tests were made in a study of the concomitant effects 
of the Levaditi virus and neurovaccine virus. 
In carrying out the experiments, when virus was to be injected in the brain, 
the usual dose of 0.15 cc. of a 10 per cent saline suspension of brain containing 
active virus was used, unless otherwise stated.  For corneal and skin injections, 
the methods of Flexner and Amos# were employed.  For intratesticular inocula- 
tion of neurovaccine virus, 0.5 cc. of a 10 per cent rabbit brain suspension,  con- 
taining active virus, was introduced into each of the testes after injury of these 
organs by repeated needle puncture.  In each instance  the specific activity of 
the viruses employed was determined by inoculation  into corresponding tissues 
of susceptible  control animals.  The period  of observation  lasted for from 15 
days to at least 1 month. 
The combinations of viruses injected into guinea pigs, and the results obtained 
follow. 
1. Levadlti C strain of herpes virus in the brain, and 2 days later neurovaccine 
virus in the cornea.  Typical neurovaccine virus keratoconjunctivitis resulted, 
from which the animals recovered without cerebral involvement. 
2. Levaditi herpes virus in the brain, and 2 days later neurovaccine virus in 
the shaved abdominal skin.  There followed no encephalitis,  only neurovaccine 
dermal lesions, from which the animals promptly recovered. 
3. Levaditi herpes virus in the brain, and 2 days later neurovaccine  virus in 
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4. Levaditi herpes virus in the brain, and at the same time neurovaccine virus 
also in the brain.  Since both viruses are inactive in guinea pigs by this method 
of injection, but produce characteristic encephalitis in rabbits after intracerebral 
inoculation, guitlea pigs were subjected to inoculation simultaneously as follows: 
(a)  the usual amount (0.15 cc.) of both viruses was injected separately in each 
hemisphere, and in another series larger amounts (0.2 cc.) were tested; (b) usual 
quantities (0.15 cc.) of the two viruses mixed in vitro were introduced into one 
hemisphere and in another test larger doses (0.2 cc.) were employed.  None of 
these animals  developed encephalitis. 
It was not found possible, therefore, to implant the Levaditi virus 
on  the  cerebrum of guinea pigs  by combining  it  with  neurovaccine 
virus in such a  way as to permit both to act with maximum effects at 
the same time. 
Cross-Immunity  in  Guinea  Pigs.  Levaditl  and  H.F.  Strains. 
Cross-immunity  in  rabbits  between  the  Levaditi  and  the  H.F. 
strains of herpes virus has been determined by Flexner and AmossY 
The  tests  to  be  reported  relate  to  the  corresponding  effects in  the 
guinea pig. 
Three series of experiments were made at different times, each series contain- 
ing 3, 6, and 3 guinea pigs immunized with Levaditi herpes virus.  In addition, 
guinea pigs and rabbits were included to serve as controls of the activity not only 
of the Levaditi virus used in the immunization, but also of the H.F. strain given 
as a  test injection later. 
The procedure of immunization consisted in injecting guinea pigs intraperi- 
toneaUy with 2 cc. of a 25 per cent saline suspension  of fresh rabbit brain con- 
taining active Levaditi virus.  Four to five such inoculations were made at 4 to 
7 day intervals.  From 7 to 10 days after the last injection, the guinea pigs were 
given intracrauially 0.2 cc. of a 10 to 20 per cent suspension of either guinea pig 
or rabbit fresh brain containing the H.F. strain of herpes virus.  The  controI 
animals showed characteristic herpes-virus encephalitis with death in 6 to 7 days, 
while the immunized guinea pigs remained well. 
Cross-immunity has therefore been shown to exist in the guinea pig 
between the Levaditi virus and the H.F. strain of herpes virus.  More- 
over, by repeated intraperitoneal injections of the Levaditi virus, dur- 
ing which no apparent signs of disease were noted, a  solid immunity 
was produced. 
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DISCUSSION  AND  SUMMARY. 
A number of methods have been employed in attempts to induce 
encephalitis in guinea pigs with the Levaditi C strain of herpes virus. 
Some of these consisted of different modes of inoculation of the virus 
itself  and  others  of  different ways  of  combining it  with  vesicular 
stomatitis and neurovaccine viruses so as to obtain the concomitant 
effects of both.  In still another test the Levaditi virus was combined 
with  the  neurovaccine in  a  manner  calculated  to  bring  about  the 
maximum action of each at  the same time.  By all these methods, 
the Levaditi virus failed to evoke the characteristic encephalitis which 
this specimen is capable of inducing uniformly in rabbits.  On the 
other hand,  when the Levaditi herpes virus is  inoculated into  the 
brain  of guinea pigs in conjunction with suitably timed corneal in- 
jections, it acquires active encephalitogenic properties. 
The results just noted suggest several considerations: 
1.  The possibility of increasing the virulence of  a  filtrable  virus 
by animal passage in a  special manner.  It is not likely that the in- 
crease as observed was due to dosage, for after the virus acquired its 
encephalitogenic property for guinea pigs, the usual amounts of virus 
suspensions sufficed to induce, in a uniform way, typical encephalitis. 
2.  The opinion previously expressed by  Flexner  ~ that  the guinea 
pig serves merely to separate weak from strong strains of herpesvirus 
is supported: for only according to the particular method described, 
could the encephalitogenic power of the Levaditi virus be developed 
and the weak be converted into a  strong herpes  strain.  With the 
acquisition of this power, the Levaditi virus acted in precisely the 
same manner as strong herpes strains both in the guinea pig and the 
rabbit.  Moreover, it was shown in guinea pigs that cross-immunity 
occurs between weak and strong strains. 
3.  The two samples of neurovaccine virus employed were incapable 
of inducing encephalitis  in guinea pigs after intracutaneous, intratestic- 
ular, corneal, or intracerebral inoculation, although they were actively 
encephalitogenic in  rabbits.  In  spite of  the fact  that  the vaccine 
virus and herpes virus are different, as shown by the histopathology 
and absence of cross-immunity, they behave in the same way when 
injected into the brain of the guinea pig.  The failure of the concomi- PETER  K. OLITSKY AND  PERRIN  11".  LONG  391 
tant action of both viruses to induce encephalitis in the guinea pig 
suggests that the association of two viruses, under the experimental 
conditions outlined, is incapable of inducing encephalitis, if  either, 
by itself, is non-encephalitogenic. 
4.  The  serum  from  normal  guinea  pigs  may  neutralize  a  weak 
(Levaditi C)  but not a  strong (H.F.)  strain of herpes virus; but the 
neutralizing action of the serum on Levaditi C virus is not uniform. 
5.  The Levaditi strain of virus can increase in quantity in the brain 
of the guinea pig to a degree which permits detection and yet fails to 
evoke  any  distinctive  clinical picture  or  definite  histopathological 
changes. 
6.  Repeated intraperitoneal injections of Levaditi virus in guinea 
pigs elicit no signs of infection, yet they induce a  solid immunity to 
strong strains of herpes virus. 